[
  {
    "id": "42-non-invasive-ventilation-ocr-complete--1--chunk-0",
    "bookId": "42-non-invasive-ventilation-ocr-complete--1-",
    "sectionTitle": "NIV Principles & Monitoring",
    "content": "<!-- Page 1 -->\n\n\n\n# NIV Principles & Monitoring\n\nDr. A. Sateesh Chandra MD,DM\nPulmonary & Critical Care Medicine\n\n---\n\n<!-- Page 2 -->\n\nOutline\n\n*   Types of non invasive ventilators\n*   Ventilator circuits\n*   NIV interfaces\n*   NIV modes\n*   NIV settings\n*   Monitoring & trouble shooting\n\nFB: Ventilator waves\n\n---\n\n<!-- Page 3 -->\n\nVentilators for NIV\n\nCritical care ventilators\nBilevel ventilators\n\n---\n\n<!-- Page 4 -->\n\nThere is no discernible text in the provided image.\n\n---\n\n<!-- Page 5 -->\n\n\n\n# Bilevel / Portable Ventilators\n\n\n\n## Advantages\n* Better leak compensation- improved patient triggering and synchrony\n\n\n\n## Disadvantages\n* No waveform display\n* Single limb- can cause CO‚ÇÇ rebreathing\n* No oxygen blenders\n* Limited pressure delivery\n* No alarms\n\n---\n\n<!-- Page 6 -->\n\n\n\n# Circuit\n\n*   **A** Single limb\n*   **C** Single limb, exhalation valve\n*   **D** Single limb, exhalation valve, flow sensor\n*   **E** Dual limb, exhalation valve, flow sensor\n\n---\n\n<!-- Page 7 -->\n\n\n\n# NIV Circuits\n\n\n\n## A Single limb circuit with a leak port\n*   Ventilator\n*   Leak\n*   Patient\n\n\n\n## B Single limb circuit with active exhalation valve\n*   Ventilator\n*   Pressurization line\n*   Active exhalation valve\n*   Patient\n\n\n\n## C Dual limb circuit\n*   Ventilator\n*   Patient\n\n---\n\n<!-- Page 8 -->\n\n\n\n# NIV INTERFACES\n\n\n\n## Select mask type\n\n*   Full Face\n*   Pillows\n*   Nasal\n*   Nasal Ultra\n*   Paediatric\n*   Leak valve: Use with Non-Vented (NV) mask\n\n---\n\n<!-- Page 9 -->\n\n\n\n# Vented Masks\n\n*   One or multiple holes for CO‚ÇÇ removal\n*   Single limb circuit\n\n\n\n# Non-Vented Masks\n\n*   No holes/Completely closed\n*   Dual limb circuit\n*   Single limb circuit with active exhalation valve\n\n---\n\n<!-- Page 10 -->\n\nS\nAcuCare\nSINGLE USE ONLY\n\nM\nAcuCare\nSINGLE USE ONLY\n\n---\n\n<!-- Page 11 -->\n\nHelmet mask\nFull Face mask\nOronasal mask/ Face mask\nNasal mask/ Nasal pillows\nOral mask\n\n---\n\n<!-- Page 12 -->\n\nNasal Pillow\nNasal Mask\n\n---\n\n<!-- Page 13 -->\n\nOronasal Mask/\nFace Mask\n\nFull Face Mask\n\n---\n\n<!-- Page 14 -->\n\nOral Mask\nHelmet Mask\n\n---\n\n<!-- Page 15 -->\n\n\n\n# Nasal Mask & Nasal Pillows\n\n\n\n## Advantages\n*   Talking\n*   Eating\n*   Expectoration\n*   Lower risk of vomiting, asphyxia\n*   Less claustrophobia\n\n\n\n## Disadvantages\n*   Not possible with nasal obstruction, mouth breathing in ARF\n*   Nasal irritation, dryness, congestion\n*   Leaks with mouth open\n*   V$_T$ can't be measured\n*   Dry mouth\n\n---\n\n<!-- Page 16 -->\n\nOronasal mask (Face mask) & Full face mask\n\n\n\n### Advantages\n*   Lesser air leak\n*   Easier to fit\n*   Preferred masks in case of in mouth breathing and acute respiratory failure\n\n\n\n### Disadvantages\n*   Vomiting, Aspiration, Asphyxia\n*   Claustrophobia\n*   Nasal, face pressure sores\n*   Talking & coughing difficult\n*   Drying of eyes\n\n---\n\n<!-- Page 17 -->\n\nOral Mask\n\n*   Vomiting\n*   Hypersalivation\n*   Gastric distension\n*   Talking & eating difficult\n*   Pressure loss through nose\n\nUsed in neuromuscular disorders\n\n---\n\n<!-- Page 18 -->\n\nHelmet ventilation apparatus\nHood\nPatient access and antisuffocation port\nExpiratory limb\nNasogastric feeding tube\nSoft collar\nUnderarm strap\nSeal connector\nInspiratory limb\n\n---\n\n<!-- Page 19 -->\n\n\n\n## Helmet Mask\n\n\n\n### Advantages:\n*   Ability to deliver higher PEEP levels for prolonged durations because of minimal leak\n*   No skin lesions or pressure ulcers due to the helmet's lack of contact with the face\n*   Less resistance to flow\n*   Can be applied regardless of the facial contour, facial trauma, or edentulism\n*   Allows coughing\n*   Less need for patient cooperation\n*   Better comfort\n*   Less interference with speech\n*   Less risk of aerosol dispersion\n\n---\n\n<!-- Page 20 -->\n\nDisadvantages\n* Can not measure tidal volumes\n* Asynchronies-trigger delay, slow pressurisation, cycling delay\n* CO‚ÇÇ rebreathing\n* Noise\n* Edema of the limbs\n\n---\n\n<!-- Page 21 -->\n\n\n\n# Choice of mask\n\n*   In ARF Patients often start mouth breathing to bypass the higher resistance of the nose. This can result in mouth leaks and compromise the efficacy of ventilation if nasal masks are used.\n*   All interfaces can be used to provide NIV successfully, but in the acute setting interfaces covering the mouth and nose are advantageous.\n*   Try switching to a smaller interface once the patient is more stable.\n*   There is currently no strong scientific evidence that one type of mask is necessarily or consistently better than others in terms of clinical efficiency.\n\n---\n\n<!-- Page 22 -->\n\n\n\n# Selecting correct interface size\n\n*   The nasal mask should fit just above the junction of the nasal bone and cartilage, directly at the sides of both nares, and just below the nose above the upper lip.\n*   The oronasal mask should fit from just above the junction of the nasal bone and cartilage to just below the lower lip.\n\n---\n\n<!-- Page 23 -->\n\nSizeMe‚Ñ¢\nXS\nS\nM\nL\nF&P Nivairo‚Ñ¢\n\nVented Hospital Full Face Mask\nAnti-Asphyxiation Valve Version\nRT047\nSize\nS\nFull Face\nVented\nFisher & Paykel\nHEALTHCARE\n\n---\n\n<!-- Page 24 -->\n\n\n\n# NIV MODES\n\nSettings\nMode\n* CPAP\n* S\n* ST\n* T\n* IVAPS\n* PAC\n\n---\n\n<!-- Page 25 -->\n\n\n\n# CPAP & BPAP\n\n*   **CPAP (Continuous Positive Airway Pressure)**\n    *   Maintains a constant pressure throughout the breath\n\n*   **BPAP (Bilevel Positive Airway Pressure)**\n    *   Two levels of pressure applied\n    *   Expiratory positive airway pressure/EPAP\n    *   Inspiratory positive airway pressure/ IPAP\n    *   Difference between IPAP & EPAP is pressure support\n    *   Modes: Spontaneous (S), Timed (T), Spontaneous/Timed (S/T), PAC\n\n---\n\n<!-- Page 26 -->\n\n\n\n# SPONTANEOUS MODE ( S )\n\n*   Breaths are patient triggered & patient cycled\n*   No option to set RR\n*   RR is determined by the patient\n*   Ventilator delivered breaths = patient's spontaneous RR\n\nDisadvantages:\n\n*   Patient's RR ‚Üì, ventilator delivered breaths ‚Üì\n*   Ventilator will not deliver breaths if patient is not breathing\n\n---\n\n<!-- Page 27 -->\n\n\n\n# TIMED MODE (T)\n\n*   Breaths are machine triggered (time trigger) and machine cycled (time cycled)\n*   Operator sets RR and inspiratory time\n*   Ventilator starts IPAP after preset time interval (depends on set RR)\n*   Ventilator switches to EPAP after preset inspiratory time\n\n**Example**\n*   Set RR 15 & inspiratory time 1 second\n*   Ventilator delivers a breath after every 4 seconds (60/15=4)\n*   Ventilator ends IPAP for 1 second (cycles into expiration/ starts EPAP)\n\n**Disadvantage:**\n*   Ventilator delivers fixed number of breaths regardless of the patient's spontaneous RR\n*   Poorly tolerated by patients because of lack of interaction between the patient and ventilator\n*   Used very rarely\n\n---\n\n<!-- Page 28 -->\n\n\n\n# Spontaneous/ Timed (S/T)\n\nOperator sets Back up RR\n*   If the patient's RR > backup RR: Resembles spontaneous mode\n*   If the patient's RR < backup RR: Resembles timed mode\n\n---\n\n<!-- Page 29 -->\n\n\n\n# Timed / T mode\n\n**Set RR 15**\n\n*   Patient not breathing\n    *   Ventilator delivers\n        15 breaths\n*   Patient's RR 8\n    *   Ventilator delivers\n        15 breaths\n*   Patient's RR 25\n    *   Ventilator delivers\n        15 breaths\n\n*Ventilator delivers fixed number of breaths regardless of the patient's spontaneous RR*\n\nAll breaths are machine triggered and machine cycled (Time trigger/Time cycle)\n\n---\n\n<!-- Page 30 -->\n\nSpontaneous / S mode\n\nNo option to set RR\n*   Patient not breathing\n    *   Ventilator delivers ZERO breaths\n*   Patient's RR 8\n    *   Ventilator delivers 8 breaths\n*   Patient's RR 25\n    *   Ventilator delivers 25 breaths\n\nVentilator delivers breaths equal to the patient's spontaneous RR\nAll breaths are patient triggered and patient cycled (flow cycling)\n\n---\n\n<!-- Page 31 -->\n\n\n\n# Spontaneous/Timed (S/T)\n\n**Back up RR 15**\n\n*   **Patient not breathing**\n    Ventilator delivers 15 breaths\n    Machine triggered & Machine cycled\n\n*   **Patient's RR 8**\n    Ventilator delivers 15 breaths\n    8 breaths patient triggered and patient cycled\n    7 breaths machine triggered and machine cycled\n\n*   **Patient's RR 25**\n    Ventilator delivers 25 breaths\n    Patient triggered and patient cycled\n\n---\n\n<!-- Page 32 -->\n\nOesophageal pressure\nPatient's RR 20\nEach breath 3 seconds/ patient inhales after every 3 seconds\n\nS MODE\nRR not preset\nVentilator delivers a breath after every 3 seconds\n\nT MODE\nSet RR 15\nVentilator delivers breath after every 4 seconds\n\nS/T MODE\nBackup RR 15\nVentilator delivers a breath after every 3 seconds\n\n---\n\n<!-- Page 33 -->\n\nOesophageal pressure\n6 seconds\nPatient's RR 10\nEach breath 6 seconds/ patient inhales after every 6 seconds\n\nS MODE\n6 seconds\nRR not preset\nVentilator delivers a breath after every 6 seconds (10 breaths/min)\n\nT MODE\n4 seconds\nSet RR 15\nVentilator delivers a breath after every 4 seconds\n\nS/T MODE\n4 seconds\nBackup RR 15\nVentilator delivers 15 breaths (10 breaths patient initiated + 5 breaths ventilator initiated)\n\n---\n\n<!-- Page 34 -->\n\nOesophageal pressure\nPatient's RR zero\n\nS MODE\nVentilator delivered breaths zero\n\nT MODE\n(Waveform showing square pulses)\n4 seconds (indicated by an arrow between pulses)\nSet RR 15\nVentilator delivers a breath after every 4 seconds\n\nS/T MODE\n(Waveform showing square pulses)\n4 seconds (indicated by an arrow between pulses)\nBackup RR 15\nVentilator delivers a breath after every 4 seconds\n\n---\n\n<!-- Page 35 -->\n\n**Spontaneous**\n*   Ventilators do not deliver breaths if patient is not breathing\n*   Ventilator delivers a breath when patient inhales and the all inspiratory efforts are assisted (Good patient-ventilator synchrony)\n\n**Timed**\n*   Ventilator delivers fixed number of breaths even if the patient is not breathing\n*   Ventilator delivers fixed number of breaths at fixed interval regardless of the patient's spontaneous RR/ breathing pattern (No patient-ventilator synchrony)\n\n---\n\n<!-- Page 36 -->\n\nS <--- Patient's RR > back up RR --- S/T --- Patient's RR < back up RR ---> T\n\n---\n\n<!-- Page 37 -->",
    "wordCount": 1601,
    "index": 0,
    "subTopicId": "1766794361796-fbbt6orko"
  },
  {
    "id": "42-non-invasive-ventilation-ocr-complete--1--chunk-1",
    "bookId": "42-non-invasive-ventilation-ocr-complete--1-",
    "sectionTitle": "S",
    "content": "## S\nPatient triggered & patient cycled\n*   RR and inspiratory time are not preset\n*   Patient initiates breath\n*   Ventilator ends inspiratory phase after flow falls to certain level (flow/ patient cycling)\n*   Ventilator delivered breaths= patient's respiratory rate\n\n\n\n## S/T\n*(No text visible in the image for this section)*\n\n\n\n## T\nMachine triggered & machine cycled\n*   Preset RR and inspiratory time\n*   Ventilator initiates a breath after predetermined time interval is reached (based on set RR)\n*   Ventilator ends breath after predetermined inspiratory time\n*   Ventilator delivers breaths at a fixed rate regardless of patient's RR\n\n---\n\n<!-- Page 38 -->\n\n\n\n# Pressure Assist Control (PAC)\n\n*   Operator sets back up RR and inspiratory time\n*   If the patient's RR > set RR\n    *   All breaths are patient triggered & machine cycled\n*   If the patient's RR < set RR\n    *   Breaths are machine triggered and machine cycled\n\n---\n\n<!-- Page 39 -->\n\n\n\n## Timed Mode\n\n*   Breaths are always machine triggered\n*   Inspiratory time preset\n    (Time/machine cycled breaths)\n*   Ventilator delivers fixed number of breaths regardless of patient's spontaneous RR\n\n\n\n## PAC\n\n*   Machine triggered or patient triggered\n*   Inspiratory time preset\n    (Time/machine cycled breaths)\n*   Patient determines RR\n    *   Patient's RR > Backup RR\n        Total number of breaths = backup RR\n    *   Patient's RR < Backup RR\n        Total number of breaths = patient's RR\n\n---\n\n<!-- Page 40 -->\n\n\n\n# Settings\n\n| Setting     | Value  |\n| :---------- | :----- |\n| Mode        | T      |\n| IPAP        | 24.6   |\n| EPAP        | 6.0    |\n| Resp. Rate  | 10     |\n| TI          | 2.0s   |\n| Rise Time   | 900ms  |\n| Mask        | Nasal  |\n\n\n\n# Settings\n\n| Setting     | Value  |\n| :---------- | :----- |\n| Mode        | PAC    |\n| IPAP        | 24.6   |\n| EPAP        | 6.0    |\n| Backup Rate | 10     |\n| TI          | 2.0s   |\n| Rise Time   | 900ms  |\n| Trigger     | High   |\n\n---\n\n<!-- Page 41 -->\n\n**NIV Pressure Control**\n\n**Basic**\n*   PC above PEEP: 5 cmH‚ÇÇO\n*   Resp. Rate: 15 b/min\n*   PEEP: 5 cmH‚ÇÇO\n*   O‚ÇÇ conc.: 40 %\n\n**I:E**\n*   I:E: 1:2.0\n*   T insp. rise: 5 %\n\n---\n\n**Settings**\n*   Mode: PAC\n*   IPAP: 24.6\n*   EPAP: 6.0\n*   Backup Rate: 10\n*   TI: 2.0s\n*   Rise Time: 900ms\n*   Trigger: High\n\n---\n\n<!-- Page 42 -->\n\nNIV PS\n\nTi 1,33 s (23%)\n\n**Basic**\n*   PS above PEEP: 5 cmH‚ÇÇO\n*   PEEP: 5 cmH‚ÇÇO\n*   O‚ÇÇ conc.: 40 %\n\n**Insp. times**\n*   T insp. rise: 0,20 s\n\n**End inspiration**\n*   End inspiration: 50 %\n\n**Backup ventilation**\n*   PC above PEEP: 5 cmH‚ÇÇO\n*   Resp. Rate: 15 b/min\n*   I:E: 1:2,0\n\n---\n\n<!-- Page 43 -->\n\n\n\n# Pressure control\n\n![Pressure control - Pressure waveform](image_part_1.png)\n![Pressure control - Flow waveform with \"Time cycled\" label](image_part_2.png)\nTime cycled\n![Pressure control - Volume waveform](image_part_3.png)\n\n\n\n# Pressure support\n\n![Pressure support - Pressure waveform](image_part_4.png)\n![Pressure support - Flow waveform with \"Flow cycled\" label](image_part_5.png)\nFlow cycled\n![Pressure support - Volume waveform](image_part_6.png)\n\n---\n\n<!-- Page 44 -->\n\nInspiratory Time\nPeak inspiratory flow\n50%\n25% of peak inspiratory flow\n10%\nFLOW-TIME SCALAR\nInspiratory flow\nTime\nExpiratory flow\nExpiratory Time\n\n---\n\n<!-- Page 45 -->\n\n\n\n# Newer modes\n*   Neurally adjusted ventilator assistance (NAVA)\n*   Proportional Assist Ventilation (PAV)\n\n---\n\n<!-- Page 46 -->\n\n```markdown\nCentral Nervous System\n‚Üì\nPhrenic Nerve\n‚Üì\nDiaphragm Excitation\n‚Üì\nDiaphragm Contraction\n‚Üì\nLung Expansion\n‚Üì\nAirway Pressure\n\nCentral Nervous System ‚Üí Ideal Ventilation Mode\nIdeal Ventilation Mode ‚Üí Ventilator\n\nDiaphragm Excitation ‚Üí NAVA\nNAVA ‚Üí Ventilator\n\nAirway Pressure ‚Üí Traditional Ventilation Modes\nTraditional Ventilation Modes ‚Üí Ventilator\n```\n\n---\n\n<!-- Page 47 -->\n\nNAVA\n\n---\n\n<!-- Page 48 -->\n\nNAVA\nNAVA Ppeak est.: 24 cmH‚ÇÇO\nTI 1.33 s (33%)\n\n**Basic**\nNAVA level\n2.0 cmH‚ÇÇO/¬µV\nPEEP\n5 cmH‚ÇÇO\nO‚ÇÇ conc.\n28 %\n\n**Trigg. Edi**\nTrigg. Edi\n0.5 ¬µV\n\n**Pressure Support**\nTrigg. Flow\n5 L/min\nInsp. cycle off\n30 %\nPS above PEEP\n21 cmH‚ÇÇO\n\n**Backup ventilation**\nPC above PEEP\n20 cmH‚ÇÇO\nResp. Rate\n15 b/min\nI:E\n1:2.0\n\n---\n\n<!-- Page 49 -->\n\n\n\n# Proportional Assist Ventilation (PAV)\n\n\n\n## Equation of Motion\n\n$P_{vent} + P_{mus} = P_{resistive} + P_{elastic} + PEEP$\n\n$P_{vent} + P_{mus} = \\text{Resistance} \\times \\text{Flow} + \\text{Elastance} \\times \\text{Volume} + PEEP$\n\nResistive Load\n(Pressure required to overcome resistance)\n\nElastic Load\n(Pressure required to overcome elastance)\n\nVentilator\nPUSH\n$P_{vent}$\n\nInspiratory muscles\nPULL\n$P_{mus}$\n\n---\n\n<!-- Page 50 -->\n\n\n\n# AVAPS & IVAPS\n\n*   AVAPS\n    *   Average Volume assured Pressure Support ventilation\n*   IVAPS\n    *   Intelligent Volume assured Pressure Support ventilation\n\n---\n\n<!-- Page 51 -->\n\nMaximum PS\nMinimum PS\nTarget VT\n\n---\n\n<!-- Page 52 -->\n\nNew Mode: AVAPS\n\nVT\n500\nmL\n\nRate\n4\nBPM\n\nI-Time\n1.00\nsecs\n\nRise\n3\n\nEPAP\n4\ncmH2O\n\nMin P\n10\ncmH2O\n\nMax P\n25\ncmH2O\n\nO2\n21\n%\n\nActivate\nAVAPS\nMode\n\nCancel\n\nS/T\nSettings\n\nAlarm\nSettings\n\nModes\n\nMenu\n\nStandby\n\n(Mute/Alarm Off Icon)\n(Help Icon)\n\n---\n\n<!-- Page 53 -->\n\nVentilation mode: iVAPS\nMV: 7.0 L/min\nAvg Vt: 467 mL\nAvg Vt/kg: 6.8 mL/kg(IBW)\n\nPt Height: 70 inches\nTarget Pt rate: 15 per min\nTarget Va: 5.2 L/min\n\nEPAP: 5.0 cmH‚ÇÇO\nMin PS: 2.0 cmH‚ÇÇO\nMax PS: 20.0 cmH‚ÇÇO\n\n---\n\n<!-- Page 54 -->\n\nNIV settings\n\n---\n\n<!-- Page 55 -->\n\n\n\n# Goals of NIV\n\n*   **Oxygenation**\n    *   CPAP/EPAP/PEEP\n        *   Alveolar recruitment\n        *   Maintains upper airway patency\n        *   Decreases work of breathing by counteracting the effects of auto PEEP\n\n*   **CO‚ÇÇ removal**\n*   **Unloading respiratory muscles**\n    *   IPAP/PS\n        *   Augments tidal volume & alveolar ventilation\n\n---\n\n<!-- Page 56 -->\n\n\n\n# Physiological effects of NIV\n\n*   Alveolar collapse\n*   Alveolar oedema\n*   Consolidation\n\nThese conditions contribute to:\n\n*   V/Q mismatch\n*   Shunt\n*   Decreased compliance\n*   Decreased FRC\n\nThese, in turn, lead to:\n\n*   V/Q mismatch $\\downarrow$ Hypoxia\n*   Shunt $\\downarrow$ Hypoxia\n*   Decreased compliance $\\downarrow$ Increased work of breathing, Respiratory muscle fatigue\n*   Decreased FRC $\\downarrow$ Increased work of breathing, Respiratory muscle fatigue\n\nNIV (Non-Invasive Ventilation) addresses these issues:\n\n*   Hypoxia $\\uparrow$ NIV (via $\\text{FiO}_2$)\n*   NIV $\\uparrow$ Decreased compliance (via $\\text{EPAP/PEEP}$)\n*   NIV $\\uparrow$ Increased work of breathing, Respiratory muscle fatigue (via $\\text{IPAP/PS}$)\n\n---\n\n<!-- Page 57 -->\n\n\n\n# CPAP\n\n*   CPAP increases FRC\n*   Increases mean airway pressure\n*   Maintains upper airway patency\n*   Lung recruitment\n*   Decreases work in case of auto PEEP\n*   EPAP is necessary to ensure sufficient expiratory flow to flush carbon dioxide from the ventilatory dead space, enabling removal of carbon dioxide from the ventilator circuit and preventing rebreathing.\n*   Fixed CPAP/ Auto CPAP\n*   It does not unload respiratory muscles\n\n---\n\n<!-- Page 58 -->\n\n\n\n## How to set CPAP/EPAP/PEEP?\n\n*   Start with 3 to 5 cm H‚ÇÇO CPAP\n*   1 cm H‚ÇÇO increments\n*   Increase CPAP\n    *   To relieve obstructive apneas\n    *   To improve oxygenation\n    *   Ineffective triggering in the presence of auto PEEP\n\n* *Increase IPAP equal to EPAP increments to maintain a constant pressure support*\n\n---\n\n<!-- Page 59 -->\n\nHigh PEEP\n*   Leaks\n*   Patient discomfort\n\nLow PEEP\n*   Ineffective triggering\n*   Trigger delay\n*   Upper airway obstructions leading to arousals\n\n---\n\n<!-- Page 60 -->\n\n\n\n# IPAP & Pressure support\n\n*   Provides ventilator assistance\n*   Unloads inspiratory muscles\n*   Decreases work of breathing\n*   Augments tidal volume, minute ventilation, gas exchange\n\n*   Critical care ventilators\n    *   Pressure support is the pressure applied at the airway opening above the PEEP\n    *   e.g. PEEP 5 and pressure support 10 cm H‚ÇÇO\n    *   During inspiration airway pressure rises 10 cm H‚ÇÇO above PEEP. Total pressure 15 cmH‚ÇÇO\n*   Bilevel ventilators\n    *   IPAP is the pressure relative to atmosphere\n    *   The difference between IPAP and EPAP is the Pressure support\n    *   E.g. EPAP 5 cm H‚ÇÇO and IPAP 10 cm H‚ÇÇO.\n\n---\n\n<!-- Page 61 -->\n\n```markdown\n\n\n## CPAP\n\n**Pressure vs. Time Graph**\n\n*   **Y-axis:** Pressure\n*   **X-axis:** Time\n*   **Pressure Profile:** A continuous, constant pressure level.\n    *   Labeled \"Inspiration\" and \"Expiration\" above the line.\n    *   The constant pressure level is labeled \"CPAP\".\n\n\n\n## BPAP\n\n**Pressure vs. Time Graph**\n\n*   **Y-axis:** Pressure\n*   **X-axis:** Time\n*   **Pressure Profile:** Two distinct pressure levels.\n    *   **Inspiration:** Higher pressure level, labeled \"IPAP\".\n    *   **Expiration:** Lower pressure level, labeled \"EPAP\".\n*   **Annotations:**\n    *   **Pressure support:** The difference between IPAP and EPAP (indicated by a blue double-headed arrow).\n    *   **IPAP:** The inspiratory positive airway pressure (indicated by a green double-headed arrow from baseline to the IPAP level).\n    *   **EPAP:** The expiratory positive airway pressure (indicated by a yellow double-headed arrow from baseline to the EPAP level).\n```\n\n---\n\n<!-- Page 62 -->\n\nBilevel Ventilator\nCritical Care Ventilator\n\nEPAP 5\nIPAP 10\nPS 5\nPEEP 5\nPS 10\n\nIPAP 10 cm H‚ÇÇO $\\neq$ PS 10 cm H‚ÇÇO\n\n---\n\n<!-- Page 63 -->",
    "wordCount": 1450,
    "index": 1,
    "subTopicId": "1766794361796-fbbt6orko"
  },
  {
    "id": "42-non-invasive-ventilation-ocr-complete--1--chunk-2",
    "bookId": "42-non-invasive-ventilation-ocr-complete--1-",
    "sectionTitle": "How to set IPAP / pressure support?",
    "content": "# How to set IPAP / pressure support?\n\n*   The difference between IPAP & EPAP should be 4 to 5 cm H‚ÇÇO\n*   If the EPAP is 4, Starting IPAP 8\n*   Starting pressure support 4 to 5 cm H‚ÇÇO\n*   Increased gradually- 2 cm H‚ÇÇO increments- monitor ABG, RR, tidal volume, leaks\n*   Increase pressure support/ IPAP\n    *   To target a tidal volume of 6-8 ml/kg predicted body weight\n    *   To reduce the work of breathing and RR\n    *   To correct hypercapnia\n\n---\n\n<!-- Page 64 -->\n\n* High pressures\n    * High tidal volume\n    * Ventilator over assistance\n    * Leaks\n    * Gastric distension/insufflation, vomiting, aspiration\n    * Auto PEEP\n    * Ineffective triggering, late cycling\n* Low pressure support\n    * Ventilator under assistance, dyspnoea\n    * Hypercarbia\n    * Increases work of breathing\n\n---\n\n<!-- Page 65 -->\n\n\n\n# Respiratory Rate\n\n*   Setting a backup respiratory rate ensures minimal ventilation when the patient is unable to trigger a mechanical breath.\n*   The backup respiratory rate should be set to less than the patient's spontaneous respiratory rate to favour breaths triggered by the patient, which are more efficient and may also be more comfortable.\n*   COPD- low RR\n*   ARDS - high RR\n\n---\n\n<!-- Page 66 -->\n\n\n\n# Rise Time\n\n*   **PEEP**\n*   **Pressure-Time**\n\nThe image displays three pressure-time waveforms, illustrating different \"Rise Times\".\n\n1.  **Left (Blue Waveform):** Shows an almost instantaneous rise in pressure from the PEEP level to the peak inspiratory pressure, followed by a plateau and then a rapid drop back to PEEP. This represents a very fast rise time.\n2.  **Middle (Red Waveform):** Shows a moderately sloped rise in pressure from the PEEP level to the peak inspiratory pressure, followed by a plateau and then a rapid drop back to PEEP. A double-headed arrow indicates the duration of this rise, labeled as \"Rise Time\".\n3.  **Right (Green Waveform):** Shows a more gradual, slower rise in pressure from the PEEP level to the peak inspiratory pressure, followed by a plateau and then a rapid drop back to PEEP. A double-headed arrow indicates the duration of this rise, also labeled as \"Rise Time\", which is longer than the red waveform's rise time.\n\n---\n\n<!-- Page 67 -->\n\n\n\n# Rise Time\n\nPressure-Time\n\nPEEP\n\nZero pressure line\n\nTime taken to reach target pressure (pressurisation rate)\n\n---\n\n<!-- Page 68 -->\n\n```\nSettings\nIPAP: 24.6\nEPAP: 6.0\nTI Max: 1.6s\nTI Min: 0.3s\nRise Time: Min\nTrigger: High\nCycle: Med\n\nSettings\nIPAP: 24.6\nEPAP: 6.0\nTI Max: 1.6s\nTI Min: 0.3s\nRise Time: 900ms\nTrigger: High\nCycle: Med\n```\n\n---\n\n<!-- Page 69 -->\n\nShort/ rapid rise time\n* Can lead to leaks, early cycling\n* Discomfort to patient\n* Flow peaks\n* Can lead to pressure overshoot leading to pressure cycling\n* May also increase RR\n\nLong pressurisation rate/ Long rise time\n* Increases work of breathing\n\n---\n\n<!-- Page 70 -->\n\nFall time/ Pressure decay time/ Expiratory slope\n\nIPAP\nEPAP\n\nIPAP\nEPAP\nFall Time\n\nTime taken to reach the EPAP level after ventilator cycles into expiration\n\n---\n\n<!-- Page 71 -->\n\nIPAP\nEPAP\nRise Time\nFall Time\nPressure- Time Scalar\n\n---\n\n<!-- Page 72 -->\n\nIPAP\nEPAP\nRise Time\nFall Time\n\nIPAP\nEPAP\nRise Time Zero\nFall Time Zero\n\n\n\n### Advanced Settings\n*   **Timin:** 0.3 sec\n*   **Time:** 1.0 sec\n*   **Trigger:** MEDIUM\n*   **Cycle:** HIGH\n*   **Rise Time:** 150\n*   **Fall Time:** 100\n*   **Mask Type:** Nasal\n\n---\n\n<!-- Page 73 -->\n\n\n\n# Inspiratory time\n\n*   Timed, PAC, PC\n*   To match neural Inspiratory time\n*   Select a short inspiratory time in COPD to prolong expiratory phase\n\n*   Short inspiratory time: early cycling\n*   Long inspiratory time: late/delayed cycling and auto PEEP\n\n---\n\n<!-- Page 74 -->\n\nProlonged inspiration/ delayed cycling\nNormal waveform/ normal cycling\nEarly termination of inspiration/ early cycling\n\n---\n\n<!-- Page 75 -->\n\nVentilation mode: (S)T\nIPAP: 12.0 cmH$_{2}$O\nEPAP: 5.0 cmH$_{2}$O\nResp. rate: 15 per min\nRise time: 300 msec\nTi Min: 0.20 sec\nTi Max: 1.50 sec\nSafety Vt: Off mL\nTrigger: High (waveform symbol)\nCycle: 30 %\nPEEP: 5.0 cmH$_{2}$O\nPS: 7.0 cmH$_{2}$O\n\n---\n\n<!-- Page 76 -->\n\n23\n90\n50\n0.0\n-50\nFlow\nPressure\nVolume\ncmH2O\n24\n20\n15\n10\n8.0\n21\n\n---\n\n<!-- Page 77 -->\n\n\n\n# T min\n\n*   Minimum time ventilator spends in inspiratory phase\n*   Safety feature that prevents early cycling\n*   The minimum inspiratory time is usually set 0.2 seconds shorter than the insufflation time\n\nE.g. T min setting 0.8 second\n*   Ventilator prevents cycling to expiration before 0.8 second\n\n---\n\n<!-- Page 78 -->\n\n\n\n# T max\n\n*   Maximum time ventilator spends in inspiratory phase\n*   Safety setting that prevents prolonged inspiration\n*   The maximum inspiratory time is usually set 0.2 seconds longer than the insufflation time\n*   E.g. T max setting 1.5 seconds\n    *   Ventilator ends inspiratory phase after 1.5 seconds regardless of patient's neural inspiratory time, set inspiratory time, and flow cycling criteria\n\n---\n\n<!-- Page 79 -->\n\n\n\n# Trigger sensitivity\n\n*   Usually flow trigger is used in NIV machines\n*   Very high, high, medium, low, very low\n*   Numerical value (1,2,3,4...) lowest number is most sensitive\n*   Automatic\n*   Very high- easy to trigger, but increases the risk of auto trigger\n*   Very low- difficult to trigger a breath, increases the risk of ineffective trigger\n\n**Settings screen:**\n*   Settings\n*   Trigger\n*   < Cancel\n*   Very Low\n*   Low\n*   Med\n*   High\n*   Very High\n\n---\n\n<!-- Page 80 -->\n\n\n\n# Cycle\n\n*   Cycling: End of inspiration and start of expiration\n*   Two types: Flow cycling, Time cycling, automatic\n*   Time cycling: Timed mode, Pressure control (PC)/Pressure assist control (PAC)\n*   Flow cycling\n    *   Percentage of peak inspiratory flow\n    *   Very low, low, medium, high, very high\n    *   Numerical value\n\n---\n\n<!-- Page 81 -->\n\nVentilation mode: (S)T\nIPAP: 12.0 cmH2O\nEPAP: 5.0 cmH2O\nResp. rate: 15 per min\nPEEP: 5.0 cmH2O\nPS: 7.0 cmH2O\nRise time: 300 msec\nTi Min: 0.20 sec\nTi Max: 1.50 sec\nSafety Vt: Off mL\nTrigger: High (waveform icon)\nCycle: 30 % (waveform icon)\n\n**Graph: Peak inspiratory flow vs. Time**\nThe graph shows inspiratory flow starting at 0, rapidly rising to a peak of 100 lit/min, then decaying exponentially. Inspiration terminates when the flow drops to 30% of the peak inspiratory flow (which is 30 lit/min in this example). Expiratory flow is shown as a negative curve, returning to zero.\n\n---\n\n<!-- Page 82 -->\n\nInspiratory Time\nPeak Inspiratory flow\nInspiratory flow\nTime\n50%\n25% of peak inspiratory flow\n10%\nFLOW-TIME SCALAR\nExpiratory flow\nExpiratory Time\n\n---\n\n<!-- Page 83 -->\n\nPeak inspiratory flow\nFlow\nTime\nVery high\nHigh\nMedium\nLow\nVery low\n\nSettings\nCycle\n< Cancel\nVery Low\nLow\nMed\nHigh\nVery High\n\n---\n\n<!-- Page 84 -->\n\nRamp Time\nPressure\nTime\n\nTarget/ Therapy CPAP\nStarting CPAP\nRamp Time\n\nExample\nSet CPAP 8 cm H‚ÇÇO\nStarting CPAP 2 cm H‚ÇÇO\nRamp time 15 seconds\n\n---\n\n<!-- Page 85 -->\n\nPressure\nTime\nStarting CPAP\nTarget/ therapy CPAP\nRamp Time\nRise Time\n\n---\n\n<!-- Page 86 -->\n\nSettings üîí\n< Home\nTherapy\nMode CPAP\nSet Pressure 6.0\nMask Nasal\nComfort\nRamp Time 10min.\n\n---\n\n<!-- Page 87 -->\n\nPressure\nTime\nStarting CPAP\nSet CPAP\nRamp up\nRamp down\n\n---\n\n<!-- Page 88 -->\n\nIPAP\nEPAP\nRamp Down\n\n---\n\n<!-- Page 89 -->\n\n\n\n# Oxygenation\n\n*   Can not set FiO‚ÇÇ in bilevel ventilators\n*   Supplemental oxygen should be attached\n    *   To BPAP machine\n    *   To the circuit through accessory port\n    *   To the mask\n    *   Nasal cannula to the patient and attach mask over the nasal prongs\n\n---\n\n<!-- Page 90 -->\n\n\n\n# Monitoring & Trouble shooting during NIV\n\n---\n\n<!-- Page 91 -->\n\n\n\n# Mask Related Problems/ Complications of NIV\n\n*   Eye irritation\n*   Nasal dryness/ congestion\n*   Dry mouth\n*   Aerophagia\n*   Claustrophobia\n*   Pressure sores\n*   Air leaks\n\n---\n\n<!-- Page 92 -->\n\n\n\n# Mask Size\n\n| Size | Distance H (mm) |\n| :--: | :-------------: |\n| S    | $80 < H < 90$   |\n| M    | $90 < H < 100$  |\n| L    | $100 < H < 115$ |\n\n---\n\n<!-- Page 93 -->\n\nReducing pressure ulcers\n\nCushions, pads, fore head spacers\n\n---\n\n<!-- Page 94 -->\n\nHeadstraps tension\nAir leaks\nSkin breakdown\n\n---\n\n<!-- Page 95 -->\n\n\n\n# Two finger rule\n\n---\n\n<!-- Page 96 -->\n\nMy Options\nMask Fit\nGood\nStop Mask Fit\n\nMask Fit\nAdjust\nStop Mask Fit\n\n---\n\n<!-- Page 97 -->\n\nRotation of masks\n\n---\n\n<!-- Page 98 -->\n\nThere is no text present in the provided image. The image contains only anatomical diagrams with arrows.\n\n---\n\n<!-- Page 99 -->\n\nThere is no text present in the provided image.\n\n---\n\n<!-- Page 100 -->\n\nNo text was found in the provided image.\n\n---\n\n<!-- Page 101 -->\n\n\n\n# Dryness\n\n*   Nasal/oral dryness and nasal congestion usually indicates air leakage through the mouth, which results in the loss of the nasal mucosal capacity to heat and to humidify inspired air\n*   Increased nasal congestion and nasal resistance reduces tidal volume and causes patient discomfort\n*   Solutions: Heated humidification, reducing the leak, using oronasal masks\n\n---\n\n<!-- Page 102 -->\n\n\n\n# Humidification\n\n\n\n## My Options\n*   Home\n*   Ramp Time: 20min.\n*   Humidity Level: 4\n*   Mask: Nasal\n*   Run Mask Fit\n*   Airplane Mode: Off\n\n\n\n## My Options\n*   Humidity Level: 4\n\n---\n\n<!-- Page 103 -->\n\nLarynx (voicebox)\nTrachea (windpipe)\nEpiglottis\nSupraglottis\nGlottis\nSubglottis\nOesophagus (gullet)\n\n---\n\n<!-- Page 104 -->",
    "wordCount": 1576,
    "index": 2,
    "subTopicId": "1766794361796-fbbt6orko"
  },
  {
    "id": "42-non-invasive-ventilation-ocr-complete--1--chunk-3",
    "bookId": "42-non-invasive-ventilation-ocr-complete--1-",
    "sectionTitle": "Aerophagia",
    "content": "# Aerophagia\n\n*   During NIV, the ventilation volume distributes between lungs and stomach depending on respiratory system resistance and lower oesophageal sphincter pressure (20-25 cm H‚ÇÇO).\n*   Predisposing factors: large tidal volumes, high pressure setting, high airway resistance, low respiratory system compliance, short inspiratory time, short rise time.\n*   Gastric distension compresses the lungs, thereby decreasing lung compliance and requiring higher airway ventilation pressure. The latter is also associated with increased risk of gastric distension, thus generating a vicious cycle.\n*   Symptoms-bloating, abdominal distention, flatulence, or excessive belching\n\n---\n\n<!-- Page 105 -->\n\nCO‚ÇÇ rebreathing\nVentilator\nVentilator\nVentilator\n\n---\n\n<!-- Page 106 -->\n\n\n\n# CO‚ÇÇ Rebreathing\n\n*   Leak port in the mask rather than in the circuit\n*   Minimum PEEP of 4 cm H‚ÇÇO in single limb circuit with passive exhalation valve\n*   Using active exhalation valve instead of passive exhalation valve\n*   Increase expiratory time, ensure adequate tidal volumes, and reduce RR\n*   Maintain high gas flow rates (40-60 L/min) in helmet masks\n\n---\n\n<!-- Page 107 -->\n\nAvoiding CO‚ÇÇ rebreathing\n\nUse minimum PEEP of 4 cm H2O with single limb circuits with passive exhalation port to avoid rebreathing\n\nNo risk of rebreathing\nPEEP not required to avoid rebreathing\n\n---\n\n<!-- Page 108 -->\n\n\n\n# Air Leaks\n\nA Single limb circuit with a leak port\n\nVentilator\nLeak\nPatient\n\nIntentional Leaks/ calibrated leaks\n\n---\n\n<!-- Page 109 -->\n\n\n\n# Unintentional Leaks\n\nBetween mask & face\nThrough mouth (Nasal masks)\nThrough nose (Oral masks)\nStomach (internal leaks)\n\n---\n\n<!-- Page 110 -->\n\n\n\n# Unintentional Leaks\n\nLoose connections\n\n---\n\n<!-- Page 111 -->\n\n\n\n# Leaks\n\n*   Trigger delay, Ineffective triggering, Auto triggering\n*   Decreased pressurization rate\n*   Decreases pressure transmission to patient\n*   Cycle delay\n*   Loss of PEEP\n*   Can not measure tidal volumes\n*   Decreased FiO‚ÇÇ\n*   Higher flows delivered to compensate leak will further impair leak\n*   Large leaks\n    *   Failure of leak compensation mechanism\n    *   May not deliver breath (disconnection alarm)\n*   Reduced patient tolerance\n*   Dryness or congestion in the nose\n*   Eye irritation\n*   Sleep disturbances\n*   Decreased compliance\n\n---\n\n<!-- Page 112 -->\n\n\n\n# Interventions to reduce air leak\n\n*   Ensure proper interface type, size, and securing system\n*   Hydrogel or foam seal, lip seal or mouth taping\n*   A chin strap can be used to prevent mouth breathing in patients using nasal masks\n*   Decreasing pressure support\n*   Tube adaptors for NG tube\n*   Leaks are minimal with helmet mask\n\n---\n\n<!-- Page 113 -->\n\nCritical Care ventilator to Bilevel ventilator\n\nCritical Care Ventilator\n\nBilevel Ventilator\n\nIPAP and EPAP settings\nPEEP=EPAP\nPS+PEEP=IPAP\n\n---\n\n<!-- Page 114 -->\n\nDon't forget to select NIV specific modes!\n\n**Left Screen:**\n*   **Top Bar:** NIV PS, Admit patient, Nebulizer, Status Q\n*   **Main Display:** Standby\n*   **Action Button:** Start ventilation\n*   **System Checks:**\n    *   Pre-use check 03-27, 12:36 Passed\n    *   Patient circuit test 03-27, 12:36 Passed\n*   **Patient Type Selection:** Adult, Infant\n*   **Ventilation Type Selection:** Invasive ventilation, NIV\n*   **Settings Bar:** Additional settings, O‚ÇÇ conc. 40, PEEP 5, PS above PEEP 5, Additional values\n\n**Right Screen:**\n*   **Patient Section:**\n    *   Adult\n    *   Female icon, 160 cm, 57 kg IBW\n    *   No Lung Injury\n*   **Circuit Section:**\n    *   Invasive\n    *   NIV (highlighted)\n    *   HFOT\n    *   Circuit icon E\n\nPS mode is available as both Invasive and Non-invasive mode, but NIV PS has better leak compensation- less incidence of asynchronies\n\n---\n\n<!-- Page 115 -->\n\nCauses of NIV failure\n\n*   **NIV failure**\n    *   Disease\n    *   Patient\n    *   Physician\n\n---\n\n<!-- Page 116 -->\n\n\n\n# Conclusion\n\n*   Strongest evidence- COPD, cardiogenic pulmonary oedema.\n*   Selecting proper interface and fitting of the mask.\n*   There is currently no strong scientific evidence that one type of mask is necessarily or consistently better than others in terms of clinical efficiency.\n*   Every effort should be made to minimize air leaks, maximize patient comfort, and optimize patient-ventilator interactions.\n\n---\n\n<!-- Page 117 -->\n\nThank You\n\nDr. A. Sateesh Chandra MD,DM\n\n---\n\n<!-- Page 118 -->\n\n\n\n## GUIDELINES/POSITION STATEMENTS\n\n\n\n### ISCCM Guidelines for the Use of Non-invasive Ventilation in Acute Respiratory Failure in Adult ICUs\nRajesh Chawla¬π, Subhal B Dixit¬≤, Kapil Gangadhar Zirpe¬≥, Dhruva Chaudhry‚Å¥, G C Khilnani‚Åµ, Yatin Mehta‚Å∂, Khalid Ismail Khatib‚Å∑, Bharat G Jagiasi‚Å∏, Gunjan Chanchalani‚Åπ, Rajesh C Mishra¬π‚Å∞, Srinivas Samavedam¬π¬π, Deepak Govil¬π¬≤, Sachin Gupta¬π¬≥, Shirish Prayag¬π‚Å¥, Suresh Ramasubban¬π‚Åµ, Jayesh Dobariya¬π‚Å∂, Vikas Marwah¬π‚Å∑, Inder Sehgal¬π‚Å∏, Sameer Arvind Jog¬π‚Åπ, Atul Prabhakar Kulkarni¬≤‚Å∞\n\n\n\n## NIV APPLICATIONS\n\n\n\n### Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure\nBram Rochwerg¬π, Laurent Brochard¬≤,¬≥, Mark W. Elliott‚Å¥, Dean Hess‚Åµ, Nicholas S. Hill‚Å∂, Stefano Nava‚Å∑ and Paolo Navalesi‚Å∏ (members of the steering committee); Massimo Antonelli‚Åπ, Jan Brozek¬π, Giorgio Conti‚Åπ, Miquel Ferrer¬π‚Å∞.\n\nDR. BHARATH KATHI MD DMS FIP FACI EDARM\n118\n\n---\n\n<!-- Page 119 -->\n\n\n\n# AGENDA\n\n- NIV UTILITY ‚úì\n- CONTRAINDICATIONS ‚úó\n- DISEASE SPECIFIC ROLE ??\n- WEANING\n- FAILURE PREDICTORS (HACOR SCORE)\n\nDR. BHARATH KATHI MD DNB FIP FACI EDARM\n\n---\n\n<!-- Page 120 -->\n\n\n\n# NIV UTILITY\n\n\n\n## Acute Hypercapnic Resp Failure\n*   AE COPD ‚úì‚úì\n*   Acute asthma ??\n*   AE Bronchiectasis\n*   Obesity\n*   hypoventilation synd ‚úì\n*   Neuromuscular disease ‚úì\n*   Chest wall deformity ‚úì\n\n\n\n## Acute Hypoxemic Resp Failure\n*   Acute pulmonary edema\n*   ARDS ?\n*   Pneumonia ?\n*   Multifactorial resp failure in I/C - ‚úì\n\n\n\n## Special conditions\n*   Post extubation\n*   Weaning in progress\n*   Chest trauma\n*   Pre / post operative\n*   NIV during procedures\n\n---\n\n<!-- Page 121 (Error: No content extracted) -->\n\n<!-- Page 122 -->\n\n\n\n## COMMON CONDITIONS IN CLINICAL PRACTICE\n?? NIV\n\n*   E COPD\n*   CARDIOGENIC PULMONARY EDEMA\n*   ASTHMA EXACERBATION\n*   PNEUMONIA in immunocompromised\n*   ARDS\n*   Post OP ARF [Acute Resp failure]\n*   Chest trauma\n*   weaning\n\n(Image: A road sign pointing left with the text \"Evidence Based\")\n\nDR. BHARATH KATHI MD DNB FIP FACI EDARM\n\n---\n\n<!-- Page 123 -->\n\n\n\n# COPD EXACERBATION\n\n\n\n## INDICATIONS FOR NONINVASIVE MECHANICAL VENTILATION (NIV)\n\nAt least one of the following:\n*   Respiratory acidosis (PaCO‚ÇÇ $\\ge$ 6.0 kPa or 45 mmHg and arterial pH $\\le$ 7.35).\n*   Severe dyspnea with clinical signs suggestive of respiratory muscle fatigue, increased work of breathing, or both, such as use of respiratory accessory muscles, paradoxical motion of the abdomen, or retraction of the intercostal spaces.\n*   Persistent hypoxemia despite supplemental oxygen therapy.\n\nTABLE 5.6\n\nDR. BHARATH KATHI MD DNB FIP FACI EDARM\n\n---\n\n<!-- Page 124 -->\n\n\n\n# INDICATIONS FOR INVASIVE MECHANICAL VENTILATION\n\n*   Unable to tolerate NIV or NIV failure.\n*   Status post - respiratory or cardiac arrest.\n*   Diminished consciousness, psychomotor agitation inadequately controlled by sedation.\n*   Massive aspiration or persistent vomiting.\n*   Persistent inability to remove respiratory secretions.\n*   Severe hemodynamic instability without response to fluids and vasoactive drugs.\n*   Severe ventricular or supraventricular arrhythmias.\n*   Life-threatening hypoxemia in patients unable to tolerate NIV.\n\nTABLE 5.7\n\nDR. BHARATH KATHI MD DNB FIP FACI EDARM\n124\n\n---\n\n<!-- Page 125 -->\n\nROLE IN COPD\n\n1) To prevent acute respiratory acidosis, i.e. when the arterial CO2 tension (PaCO2) is normal or elevated but pH is normal\n2) To prevent endotracheal intubation and invasive mechanical ventilation in patients with mild to moderate acidosis and respiratory distress, with the aim of preventing deterioration to a point when invasive ventilation would be considered\n3) As an alternative to invasive ventilation in patients with severe acidosis and more severe respiratory distress\nThere is no lower limit of pH below which a trial of NIV is inappropriate\nHowever, the lower the pH, the greater risk of failure, and patients must be very closely monitored with rapid access to endotracheal intubation and invasive ventilation if not improving.\n\nDR. BHARATH KATHI MD DNB FIP FACI EDARM 126\n\n---\n\n<!-- Page 126 -->\n\n\n\n# Cardiogenic Pulmonary edema\n\n*   In CPE : **decreased respiratory system compliance** and alveolar flooding due to high capillary pressure associated or not with left ventricular systolic dysfunction\n*   NIV (including both bilevel and **CPAP**) in this context has the ability to **improve respiratory mechanics** and facilitate **left ventricular work by decreasing left ventricular afterload** & facilitated by the decrease in negative pressure swings generated by the respiratory muscles.\n*   **NIV is recommended** in hospital patients with **ARF**, due to **Cardiogenic pulmonary edema**. (**Strong recommendation**)\n\nDR. BHARATH KATHI MD DNB FIP FACI EDARM\n126\n\n---\n\n<!-- Page 127 -->\n\n\n\n# ASTHMA EXACERBATION\n\n*   NIV may be used, together with conventional pharmacological treatment, with the aim to decrease the respiratory muscle work that is much increased during the episodes of acute bronchoconstriction and ultimately avoid intubation and invasive mechanical ventilation.\n*   BUT there is uncertainty of evidence to recommend the use of NIV for ARF due to asthma\n\nDR. BHARATH KATHI MD DNB FIP FACI EDARM\n127\n\n---\n\n<!-- Page 128 -->\n\n\n\n# ARF IN I/C -\n\nCurrently available literature supports the use of **NIV** as a **first-line approach for managing mild to moderate ARF** in selected patients with **immunosuppression**\n\n**Several studies have reported clinical benefits of NIV**, although **strict monitoring in the ICU** and **prompt availability of invasive mechanical ventilation** are mandatory\n\n---\n\n<!-- Page 129 -->",
    "wordCount": 1506,
    "index": 3,
    "subTopicId": "1766794361796-fbbt6orko"
  },
  {
    "id": "42-non-invasive-ventilation-ocr-complete--1--chunk-4",
    "bookId": "42-non-invasive-ventilation-ocr-complete--1-",
    "sectionTitle": "NIV in de novo ARF?",
    "content": "# NIV in de novo ARF?\n[Hypoxemic]\n\nDe novo respiratory failure refers to respiratory failure occurring without prior chronic respiratory disease.\n\nMost patients in this category have hypoxaemic respiratory failure, usually defined as significant hypoxaemia (PaO2/FIO2 <200), tachypnoea (respiratory rate >30-35 min and a non-COPD diagnosis (e.g. pneumonia and/or acute respiratory distress syndrome (ARDS)).\n\nDR. BHARATH KATHI MD DNB FIP FACI EDARM\n129\n\n---\n\n<!-- Page 130 -->\n\n\n\n# ROLE in ARDS / PNEUMONIA\n\n*   The main risk of NIV for the indication of de novo ARF is to delay a needed intubation\n*   NIV may be used over conventional oxygen therapy in mild early acute hypoxemic respiratory failure (P/F ratio< 300 and > 200 mmHg), under close supervision.\n*   Strong recommendation against a trial of NIV in patients with acute hypoxemic failure with P/F ratio < 150.\n\nkranthi.krishna139@gmail.com\n\nDR. BHARATH KATHI MD DNB FIP FACI EDARM\n130\n\n---\n\n<!-- Page 131 -->\n\n\n\n# NIV IN POST OP Pts\n\n*   Surgery, particularly that approaching the diaphragm, anaesthesia and post-operative pain may all have deleterious effects on the respiratory system, causing hypoxaemia, a decrease in lung volume and atelectasis due to diaphragm dysfunction\n*   These modifications of respiratory function occur early after surgery and diaphragm dysfunction may last up to 7 days, leading to an important deterioration in arterial oxygenation\n\nDR. BHARATH KATHI MD DNB FIP FACI EDARM\n131\n\n---\n\n<!-- Page 132 -->\n\n\n\n# ROLE\n\n*   NIV may increase lung aeration and decrease the amount of atelectasis during the post-operative period of patients undergoing major abdominal surgery\n*   NIV suggested for patients with post-operative ARF. (moderate certainty of evidence.)\n\nDR. BHARATH KATHI MD DNB FIP FACI EDARM\n132\n\n---\n\n<!-- Page 133 -->\n\n\n\n# CHEST TRAUMA\n\nNIV when used in patients with chest trauma is beneficial (reduced *infectious* complications and *ICU* and hospital *stay*) when compared with use of high flow oxygen through a mask or *ETI* and invasive *MV*.\n\nNIV may be used in traumatic *flail chest* along with *adequate pain relief*.\n\nDR. BHARATH KATHI MD DNB FIP FACI EDARM\n133\n\n---\n\n<!-- Page 134 -->\n\n\n\n# NIV IN VIRAL ILLNESS\n\nNIV cannot be considered as a treatment of choice for patients with acute respiratory failure\n\nHowever, it may be reasonable to use NIV in selected patients with single organ involvement, in a strictly controlled environment with close monitoring.\n\nDR. BHARATH KATHI MD DNB FIP FACI EDARM\n134\n\n---\n\n<!-- Page 135 -->\n\n\n\n# NIV IN TB\n\nCareful use of NIV in patients with acute Tuberculosis may be considered, with effective infection control precautions to prevent airborne transmission\n\nDR. BHARATH KATHI MD DNB FIP FACI EDARM 135\n\n---\n\n<!-- Page 136 -->\n\n\n\n# NIV POST IMV\n\n*Should NIV be used to prevent respiratory failure post-extubation?*\n*Should NIV be used in the treatment of respiratory failure that develops post-extubation?*\n\nDR. BHARATH KATHI MD DNB FIP FACI EDARM 136\n\n---\n\n<!-- Page 137 -->\n\n\n\n# Should NIV be used to prevent respiratory failure post-extubation?\n\n*   NIV can be used to prevent post-extubation respiratory failure in high-risk patients post-extubation. (Conditional recommendation, low certainty of evidence.)\n*   NIV should not be used to prevent post-extubation respiratory failure in non-high-risk patients.\n\n**High Risk Patients**\n*   More than one consecutive failure of weaning trial\n*   Chronic heart failure\n*   PaCO2 >45 mm Hg after extubation\n*   More than one co-morbidity (excluding chronic heart failure)\n\nDR. BHARATH KATHI MD DNB FIP FACI EDARM\n\n---\n\n<!-- Page 138 -->\n\n**Should NIV be used in the treatment of respiratory failure that develops post-extubation?**\n\n**NIV** ***should not be used in the treatment*** of patients with ***established post-extubation respiratory failure***.\n\nDR. BHARATH KATHI MD DNB FIP FACI EDARM\n138\n\n---\n\n<!-- Page 139 -->\n\nShould NIV be used to facilitate weaning patients from invasive mechanical ventilation?\n\nWe suggest NIV be used to facilitate weaning from mechanical ventilation in patients with hypercapnic respiratory failure. (Conditional recommendation, moderate certainty of evidence.)\nWe do not make any recommendation for hypoxaemic patients.\n\nDR. BHARATH KATHI MD DNB FIP FACI EDARM\n139\n\n---\n\n<!-- Page 140 -->\n\n\n\n# WEANING from NIV\n\nTable 6: Clinical criteria to be met by patients before Weaning is attempted.\n\n| S. No | Measure                     | Character                               |\n| :---- | :-------------------------- | :-------------------------------------- |\n| 1.    | Arterial pH                 | $\\ge 7.35$                              |\n| 2.    | SpO2                        | $> 90\\%$                                |\n| 3.    | Respiratory Rate            | $\\le 25 / \\text{min}$                   |\n| 4.    | Heart rate                  | $\\le 120 / \\text{min}$                  |\n| 5.    | Systolic blood pressure     | $\\ge 90 \\text{ mmHg}$                   |\n| 6.    | Signs of respiratory distress | No agitation, diaphoresis, anxiety      |\n\nDR. BHARATH KATHI MD DNB FIP FACI EDARM\n140\n\n---\n\n<!-- Page 141 -->\n\n\n\n# STRATEGIES\n\nVaried Strategies for weaning from NIV has been described:\n*   \\* Stepwise reduction in NIV duration. \\*\n*   ‚Ä¢ Stepwise reduction in NIV pressure support.\n*   X Immediate withdrawal of NIV after stabilization. X\n\nDR. BHARATH KATHI MD DNB FIP FACI EDARM 141\n\n---\n\n<!-- Page 142 -->\n\n\n\n# Stepwise reduction in NIV duration\n\n*   Progressively reducing the duration of NIV over a period of 3-4 days\n*   Initially weaning should be carried during daytime with overnight ventilation.\n*   The daytime weaning can be divided into periods of 3 hours each and can be performed as follows ‚Äì\n*   Day 1 : NIV 3 hours ON, 1 hour OFF (except during night period),\n*   Day 2 : NIV 3 hours ON, 2 hours OFF (except during night period) and\n*   DAY 3 : NIV can be used only during the night period.\n*   NIV may be discontinued on day 4 unless continuation is clinically indicated for example, few hours daytime and six hours or more overnight.\n\nDR. BHARATH KATHI MD DNB FIP FACI EDARM\n142\n\n---\n\n<!-- Page 143 -->\n\n\n\n# FAILURE OF NIV HACOR SCORE\n\n| Variable             | Value       | Score |\n| :------------------- | :---------- | :---- |\n| Heart rate (HR)      | ‚â§ 120       | 0     |\n|                      | > 120       | 1     |\n| Acidosis (pH)        | ‚â• 7.35      | 0     |\n|                      | 7.30 - 7.34 | 2     |\n|                      | 7.25 - 7.29 | 3     |\n|                      | < 7.25      | 4     |\n| Consciousness (GCS)  | 15          | 0     |\n|                      | 13 - 14     | 2     |\n|                      | 11 - 12     | 5     |\n|                      | ‚â§ 10        | 10    |\n| Oxygenation (PaO2/FiO2) | > 200       | 0     |\n|                      | 176 - 200   | 2     |\n|                      | 151 - 175   | 3     |\n|                      | 126 - 150   | 4     |\n|                      | 101 - 125   | 5     |\n|                      | ‚â§ 100       | 6     |\n| Respiratory rate (RR) | ‚â§ 30        | 0     |\n|                      | 31 - 35     | 1     |\n|                      | 36 - 40     | 2     |\n|                      | 41 - 45     | 3     |\n|                      | > 45        | 4     |\n\nA **score of 5 or below** suggests a **low risk of NIV failure**, while a score exceeding 5 indicates a **high risk of NIV failure**.\n\nDR. BHARATH KATHI MD DNB FIP FAGI EDARM\n143\n\n---\n\n<!-- Page 144 -->\n\nEvidence of effectiveness of NIV in different conditions:\n\n| Clinical indication\\*                                   | Certainty of evidence¬∂ | Recommendation                      |\n| :------------------------------------------------------ | :--------------------- | :---------------------------------- |\n| Prevention of hypercapnia in COPD exacerbation          | $\\oplus\\oplus$         | Conditional recommendation against  |\n| Hypercapnia with COPD exacerbation                      | $\\oplus\\oplus\\oplus\\oplus$ | Strong recommendation for           |\n| Cardiogenic pulmonary oedema                            | $\\oplus\\oplus\\oplus$   | Strong recommendation for           |\n| Acute asthma exacerbation                               | $\\oplus\\oplus\\oplus$   | No recommendation made              |\n| Immunocompromised                                       | $\\oplus\\oplus\\oplus$   | Conditional recommendation for      |\n| De novo respiratory failure                             | $\\oplus\\oplus\\oplus$   | No recommendation made              |\n| Post-operative patients                                 | $\\oplus\\oplus\\oplus$   | Conditional recommendation for      |\n| Palliative care                                         | $\\oplus\\oplus\\oplus$   | Conditional recommendation for      |\n| Trauma                                                  | $\\oplus\\oplus\\oplus$   | Conditional recommendation for      |\n| Pandemic viral illness                                  | $\\oplus\\oplus$         | No recommendation made              |\n| Post-extubation in high-risk patients (prophylaxis)     | $\\oplus\\oplus$         | Conditional recommendation for      |\n| Post-extubation respiratory failure                     | $\\oplus\\oplus$         | Conditional recommendation against  |\n| Weaning in hypercapnic patients                         | $\\oplus\\oplus\\oplus$   | Conditional recommendation for      |\n\n\\* : all in the setting of acute respiratory failure;\n¬∂ : certainty of effect estimates: $\\oplus\\oplus\\oplus\\oplus$, high; $\\oplus\\oplus\\oplus$, moderate; $\\oplus\\oplus$, low; $\\oplus$, very low. 144\n\n---\n\n<!-- Page 145 -->\n\n*   When used properly\n    NIV : Not Inferior Ventilation\n\nTHANK YOU\n\nDR. BHARATH KATHI MD DNB FIP FACI EDARM\n145\n\n---",
    "wordCount": 1414,
    "index": 4,
    "subTopicId": "1766794361796-fbbt6orko"
  }
]